These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 6384162)
1. Is misonidazole neurotoxicity altered by the use of phenytoin and/or dexamethasone in RTOG 79-18 and RTOG 79-16? Nelson DF; Gillespie BW; Diener MD; Davis DR; Wasserman T; Phillips TL; Stetz J Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1731-4. PubMed ID: 6384162 [TBL] [Abstract][Full Text] [Related]
3. A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: final report of an RTOG study. Nelson DF; Diener-West M; Weinstein AS; Schoenfeld D; Nelson JS; Sause WT; Chang CH; Goodman R; Carabell S Int J Radiat Oncol Biol Phys; 1986 Oct; 12(10):1793-800. PubMed ID: 3531110 [TBL] [Abstract][Full Text] [Related]
4. A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery; preliminary results of an RTOG study. Nelson DF; Schoenfeld D; Weinstein AS; Nelson JS; Wasserman T; Goodman RL; Carabell S Int J Radiat Oncol Biol Phys; 1983 Aug; 9(8):1143-51. PubMed ID: 6347995 [TBL] [Abstract][Full Text] [Related]
5. High dose misonidazole with dexamethasone rescue: a possible approach to circumvent neurotoxicity. Urtasun RC; Tanasichuk H; Fulton D; Agboola O; Turner AR; Koziol D; Raleigh J Int J Radiat Oncol Biol Phys; 1982; 8(3-4):365-9. PubMed ID: 7107353 [TBL] [Abstract][Full Text] [Related]
6. Misonidazole combined with hyperfractionation in the management of malignant glioma. Fulton DS; Urtasun RC; Shin KH; Geggie PH; Thomas H; Muller PJ; Moody J; Tanasichuk H; Mielke B; Johnson E Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1709-12. PubMed ID: 6090367 [TBL] [Abstract][Full Text] [Related]
7. The effect of phenytoin, phenobarbitone, dexamethasone and flurbiprofen on misonidazole neurotoxicity in mice. Sheldon PW; Clarke C; Dawson KB Br J Cancer; 1984 Feb; 49(2):207-13. PubMed ID: 6696821 [TBL] [Abstract][Full Text] [Related]
8. Initial pharmacology and toxicology of intravenous desmethylmisonidazole. Coleman CN; Wasserman TH; Phillips TL; Strong JM; Urtasun RC; Schwade JG; Johnson RJ; Zagars G Int J Radiat Oncol Biol Phys; 1982; 8(3-4):371-5. PubMed ID: 7107354 [TBL] [Abstract][Full Text] [Related]
9. A phase I study of misonidazole and pelvic irradiation in patients with carcinoma of cervix. Thomas GM; Rauth AM; Black BE; Cummings BJ; Sorenti VL; Bush RS Br J Cancer; 1982 Jun; 45(6):860-8. PubMed ID: 6284190 [TBL] [Abstract][Full Text] [Related]
10. The effect of vitamin B6 on the neurotoxicity and pharmacology of desmethylmisonidazole and misonidazole: clinical and laboratory studies. Coleman CN; Hirst VK; Brown DM; Halsey J Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1381-6. PubMed ID: 6469761 [TBL] [Abstract][Full Text] [Related]
11. Misonidazole peripheral neuropathy: its relationship to plasma concentration and other drugs. Walker MD; Strike TA Cancer Clin Trials; 1980; 3(2):105-9. PubMed ID: 6253094 [TBL] [Abstract][Full Text] [Related]
13. The role of microsomal enzyme inducers in the reduction of misonidazole neurotoxicity. Jones DH; Bleehen NM; Workman P; Smith NC Br J Radiol; 1983 Nov; 56(671):865-70. PubMed ID: 6626878 [TBL] [Abstract][Full Text] [Related]
14. Misonidazole in patients receiving radical radiotherapy: pharmacokinetic effects of phenytoin, tumor response and neurotoxicity. Moore JL; Paterson IC; Dawes PJ; Henk JM Int J Radiat Oncol Biol Phys; 1982; 8(3-4):361-4. PubMed ID: 7107352 [TBL] [Abstract][Full Text] [Related]
15. A biochemical neurotoxicity study relating the neurotoxic potential of metronidazole and nitrofurantoin with misonidazole. Rose GP; Dewar AJ; Stratford IJ Int J Radiat Oncol Biol Phys; 1982; 8(3-4):781-5. PubMed ID: 7107414 [No Abstract] [Full Text] [Related]
16. The Cambridge glioma trial of misonidazole and radiation therapy with associated pharmacokinetic studies. Bleehen NM Cancer Clin Trials; 1980; 3(3):267-73. PubMed ID: 7002338 [TBL] [Abstract][Full Text] [Related]
17. The neurotoxicity of misonidazole: potential modifying role of phenytoin sodium and dexamethasone. Wasserman TH; Phillips TL; Van Raalte G; Urtasun R; Partington J; Koziol D; Schwade JG; Gangji D; Strong JM Br J Radiol; 1980 Feb; 53(626):172-3. PubMed ID: 6245744 [No Abstract] [Full Text] [Related]
18. Combined modality treatment of operated astrocytomas grade 3 and 4. A prospective and randomized study of misonidazole and radiotherapy with two different radiation schedules and subsequent CCNU chemotherapy. Stage II of a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Hatlevoll R; Lindegaard KF; Hagen S; Kristiansen K; Nesbakken R; Torvik A; Ganz JC; Mella O; Rosengren B; Ringkjöb R Cancer; 1985 Jul; 56(1):41-7. PubMed ID: 2988737 [TBL] [Abstract][Full Text] [Related]
19. [Clinical experiences with the radiosensitizer Misonidazol (author's transl)]. Bamberg M; Tamulevicius P; Streffer C; Scherer E Strahlentherapie; 1981 Aug; 157(8):524-36. PubMed ID: 7268822 [No Abstract] [Full Text] [Related]
20. Neurotoxicity of misonidazole in rats following intravenous administration. Graziano MJ; Henck JW; Meierhenry EF; Gough AW Pharmacol Res; 1996 Jun; 33(6):307-18. PubMed ID: 8971952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]